# Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis

> **NCT07726888** · — · RECRUITING · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 97 (estimated)

## Conditions studied

- Ulcerative Colitis (Disorder)
- Guselkumab

## Interventions

- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT07726888
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2026-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07726888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07726888, "Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07726888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*